Literature DB >> 16261804

Aquaculture of "non-food organisms" for natural substance production.

Gerd Liebezeit1.   

Abstract

Marine invertebrates are already sources of commercially important secondary metabolites and may become even more so as knowledge on marine natural products and chemical ecology develops. Among the producers of these compounds predominantly sponges, bryozoa and molluscs have received the attention of academic and industrial research and development. For all these invertebrate groups culture techniques have been developed encompassing in situ, laboratory and cell culture approaches for the production of natural products. Potential applications of these are not restricted to pharmaceuticals but include marine cements, biominerals and antifouling compounds. In addition, markets exist for ornamental species. All culture approaches require sound ecological knowledge about the organisms to be cultured and possible symbiotic interactions between host invertebrates and microheterotrophs.

Mesh:

Substances:

Year:  2005        PMID: 16261804

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  3 in total

Review 1.  A contemporary review of seafood allergy.

Authors:  Parvaneh Hajeb; Jinap Selamat
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

2.  Production of Chondroitin Sulphate from Head, Skeleton and Fins of Scyliorhinus canicula By-Products by Combination of Enzymatic, Chemical Precipitation and Ultrafiltration Methodologies.

Authors:  María Blanco; Javier Fraguas; Carmen G Sotelo; Ricardo I Pérez-Martín; José Antonio Vázquez
Journal:  Mar Drugs       Date:  2015-05-27       Impact factor: 5.118

Review 3.  The Phylum Bryozoa: From Biology to Biomedical Potential.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Leandro M Vieira; Robert Kiss; Marianna Carbone; Willem A L van Otterlo; Nicole B Lopanik; Andrea Waeschenbach
Journal:  Mar Drugs       Date:  2020-04-09       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.